這些新藥可能會推動生物技術和製藥類股創下新高

在癌症和心臟藥物試驗中積極的結果可能會繼續推動市場上漲。評估默克、莫德納、Summit Therapeutics 等公司的風險與機會

Positive readouts in cancer and cardiac drug trials could keep the rally going. Sizing up the stakes for Merck, Moderna, Summit Therapeutics, and more.